专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明申请

US20070135831A1 Pyloric valve corking device 有权
标题翻译：幽门阀塞塞装置
公开(公告)号：US20070135831A1
公开(公告)日：2007-06-14
申请号：US11602620
申请日：2006-11-20
申请人： Daniel Burnett
发明人： Daniel Burnett
IPC分类号： A61M29/00 , A61B17/08
CPC分类号： A61F5/0079 , A61B5/036 , A61B5/073 , A61B5/145 , A61B5/14539 , A61B5/14546 , A61B5/4238 , A61B17/12022 , A61B17/12036 , A61B17/12099 , A61B17/12136 , A61B17/12172 , A61B17/1219 , A61B2017/00876 , A61B2017/12054 , A61B2017/12086 , A61F2/24 , A61F5/003 , A61F5/0036 , A61F2002/044 , A61N1/06 , A61N1/40
摘要： Pyloric valve corking devices are disclosed herein that generally include an occluding member, expanding from a first configuration to a larger second configuration, and a bridging member extending from the occluding member. The bridging member has a length that is adapted to pass at least partially through the gastric opening, so to enable the occluding member to obstruct the gastric opening, and that is also adapted to permit the occluding member to intermittently move relative to the gastric opening. A second occluding member may be attached to the distal end of the bridging member. The reduction in flow of gastric contents into the duodenum can be actively regulated using a pump or valve, or can be passively regulated with movements of the occluding device.
摘要翻译：本文公开了幽门阀塞塞装置，其通常包括从第一构型扩展到较大的第二构造的阻塞构件以及从闭塞构件延伸的桥接构件。桥接构件具有适于至少部分地穿过胃开口的长度，从而使得阻塞构件能够阻止胃开口，并且还适于允许阻塞构件相对于胃开口间歇地移动。第二阻塞构件可以附接到桥接构件的远端。可以使用泵或阀主动调节胃内容物进入十二指肠的流量的减少，或者可以通过闭塞装置的运动被动调节。

22. 发明申请

US20070093697A1 Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature 审中-公开
标题翻译：用于检测心肺血管系统中左右分流的方法和装置
公开(公告)号：US20070093697A1
公开(公告)日：2007-04-26
申请号：US11332796
申请日：2006-01-17
申请人： Daniel Burnett , Shane Mangrum
发明人： Daniel Burnett , Shane Mangrum
IPC分类号： A61B5/00
CPC分类号： A61F7/12 , A61F2007/0094 , A61F2007/126 , A61M1/28 , A61M1/281 , A61M1/285 , A61M1/32 , A61M25/003 , A61M25/007 , A61M31/00 , A61M2025/0034 , A61M2025/0037
摘要： The present invention provides a rapid, economical test for the detection of a right to left shunt applicable to the population at large due to its safety and noninvasiveness. The intended procedure involves gaining access to the circulatory system, injecting a measurable substance, ideally during prolonged and/or repeated Valsalva maneuvers, and then rapidly and repeatedly, ideally continuously, assaying for the substance. Through the determination of the appearance of a small amount of the substance prior to the subsequent high concentrations generated by the remainder of the bolus, one may safely diagnose a meaningful communication between the right and left heart, or other right to left shunt bypassing the lungs.
摘要翻译：本发明提供了一种快速，经济的检测方法，用于检测由于其安全性和非侵入性而适用于广大群体的从左到右分流。预期的程序包括进入循环系统，注入可测量的物质，理想情况是在长时间和/或重复的Valsalva操作过程中，然后快速而反复地，理想地连续测定物质。通过在随后的高剂量浓度产生的其他高剂量之前确定少量物质的出现，可以安全地诊断右心脏和左心脏之间的有意义的通信，或者旁路旁路的其他右侧分流。

23. 发明申请

US20060253003A1 Glucose monitoring device and method 失效
标题翻译：葡萄糖监测装置及方法
公开(公告)号：US20060253003A1
公开(公告)日：2006-11-09
申请号：US11373523
申请日：2006-03-09
申请人： Michael Laufer , Daniel Burnett
发明人： Michael Laufer , Daniel Burnett
IPC分类号： A61B5/00 , A61B5/04 , A61B13/00 , A61B5/103
CPC分类号： A61B5/14532 , A61B3/06 , A61B3/113 , A61B5/0496 , A61B5/113 , A61B5/6814
摘要： A method for determining the quantity of an analyte in a fluid is described along with various components of an apparatus designed to carry out the method. The method involves habituating a patient's eye to one or more colors, measuring the recovery time, and correlating the recovery time to the quantity of the analyte. A reproducible, objective, non-attentiveness-dependant test for assessing analyte levels is further disclosed. To this end, a device that measures saccadic eye movements may be used to assess the return of vision to the prehabituated state. The method and apparatus are particularly suited for noninvasively measuring blood glucose levels.
摘要翻译：描述用于确定流体中分析物的量的方法以及设计用于执行该方法的设备的各种组件。该方法涉及将患者的眼睛习惯于一种或多种颜色，测量恢复时间，并将恢复时间与分析物的量相关联。进一步公开了用于评估分析物水平的可再现的，客观的，非关注性的测试。为此，可以使用测量眼球运动的装置来评估视觉恢复到预先制定的状态。该方法和装置特别适用于非侵入性地测量血糖水平。

24. 发明申请

US20060069400A1 Method and apparatus for anchoring implants 失效
标题翻译：锚固植入物的方法和装置
公开(公告)号：US20060069400A1
公开(公告)日：2006-03-30
申请号：US11234802
申请日：2005-09-26
申请人： Daniel Burnett , Shane Mangrum
发明人： Daniel Burnett , Shane Mangrum
IPC分类号： A61B17/00 , A61F2/24 , A61F2/04
CPC分类号： A61F2/2409 , A61B17/064 , A61B2017/0641 , A61F2/07 , A61F2/848 , A61F2002/065 , A61F2220/0008 , A61F2220/0016
摘要： Methods, devices and systems facilitate retention of a variety of therapeutic devices. Devices generally include an anchoring element, which has been designed to promote fibrotic ingrowth, and an anchored device, which has been designed to firmly engage the complementary region of the anchoring element. The anchoring element may be placed in a minimally invasive procedure temporally separated from the deployment of the anchored device. Once enough time has passed to ensure appropriate fixation of the anchoring element by tissue and cellular ingrowth at the site of placement, the anchored device may then be deployed during which it firmly engages the complementary region of the anchoring element. In this manner, a firm attachment to the implantation site may be made with a minimum of required hardware. Some embodiments are delivered through a delivery tube or catheter and while some embodiments may require laparoscopy or open surgery for one or more of the placement procedures. Some embodiments anchor devices within the cardiovascular tree while others may anchor devices within the gastrointestinal, peritoneal, pleural, pulmonary, urogynecologic, nasopharyngeal or dermatologic regions of the body.
摘要翻译：方法，装置和系统便于保留各种治疗装置。装置通常包括被设计成促进纤维化向内生长的锚固元件和已被设计成牢固地接合锚定元件的互补区域的锚定装置。锚固元件可以放置在与锚定装置的展开暂时分离的微创过程中。一旦足够的时间过去以确保锚固元件通过组织和细胞向内生长在放置位置处的适当固定，则锚定装置然后可以被展开，在该位置中，其牢固地接合锚定元件的互补区域。以这种方式，可以以最少的所需硬件来进行到植入部位的牢固附着。一些实施例通过输送管或导管递送，并且虽然一些实施例可能需要腹腔镜检查或开放手术来进行一个或多个放置过程。一些实施例锚固装置在心血管树中，而另一些实施例可以将装置锚定在身体的胃肠，腹膜，胸膜，肺，泌尿，妇科，鼻咽或皮肤病学区域内。

25. 发明申请

US20060036208A1 Implantable fluid management system for the removal of excess fluid 有权
公开(公告)号：US20060036208A1
公开(公告)日：2006-02-16
申请号：US11198079
申请日：2005-08-04
申请人： Daniel Burnett
发明人： Daniel Burnett
IPC分类号： A61M5/00
CPC分类号： A61M27/002 , A61M1/28 , A61M5/14276 , A61M5/1723 , A61M27/006 , A61M39/24 , A61M2039/248 , A61M2205/103 , A61M2205/3331 , A61M2205/3334 , A61M2205/3355 , A61M2205/8206 , A61M2205/8237 , A61M2205/8287 , A61M2210/0693 , A61M2210/101 , A61M2210/1017 , A61M2210/1053 , A61M2210/106 , A61M2210/1064 , A61M2210/1085 , A61M2210/122 , A61M2230/005 , A61M2230/208 , A61M2230/50
摘要： An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.

26. 发明申请

US20050273034A1 Implantable fluid management system for the removal of excess fluid 有权
公开(公告)号：US20050273034A1
公开(公告)日：2005-12-08
申请号：US11181539
申请日：2005-07-13
申请人： Daniel Burnett
发明人： Daniel Burnett
IPC分类号： A61M5/00 , A61M5/142 , A61M5/172 , A61M27/00
CPC分类号： A61M27/002 , A61M1/28 , A61M5/14276 , A61M5/1723 , A61M27/006 , A61M39/24 , A61M2039/248 , A61M2205/103 , A61M2205/3331 , A61M2205/3334 , A61M2205/3355 , A61M2205/8206 , A61M2205/8237 , A61M2205/8287 , A61M2210/0693 , A61M2210/101 , A61M2210/1017 , A61M2210/1053 , A61M2210/106 , A61M2210/1064 , A61M2210/1085 , A61M2210/122 , A61M2230/005 , A61M2230/208 , A61M2230/50
摘要： An implantable fluid management device, designed to drain excess fluid from a variety of locations in a living host into a second location within the host, such as the bladder of that host. The device may be used to treat ascites, chronic pericardial effusions, normopressure hydrocephalus, hydrocephalus, pulmonary edema, or any fluid collection within the body of a human, or a non-human mammal.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式